Ezio Bonvini - 24 Jun 2021 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Sr VP, Research & CSO
Signature
/s/ Lynn Cilinski, Attorney-in-Fact
Issuer symbol
MGNX
Transactions as of
24 Jun 2021
Net transactions value
$0
Form type
4
Filing time
28 Jun 2021, 20:14:43 UTC
Previous filing
18 May 2021
Next filing
16 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $349,680 +21,855 +26% $16.00 104,329 24 Jun 2021 Direct
transaction MGNX Common Stock Options Exercise $86,657 +4,221 +4% $20.53 108,550 24 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Employee stock option (right to buy) Options Exercise $349,680 -21,855 -90% $16.00 2,540 24 Jun 2021 Common Stock 21,855 $16.00 Direct F1
transaction MGNX Employee stock option (right to buy) Options Exercise $86,657 -4,221 -6.3% $20.53 63,279 24 Jun 2021 Common Stock 4,221 $20.53 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 12.5% of the shares underlying the grant became exercisable on the date reflected and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.